Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Lexicon Pharmaceuticals Inc (LXRX)  
$1.54 0.06 (3.75%) as of 4:30 Thu 4/25


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,730,000
Market Cap: 290.64(M)
Last Volume: 790,925 Avg Vol: 788,718
52 Week Range: $1 - $3.58
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Diagnostic Substances

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 9.7
Insider 3/6 Months : 10.3
Guru Rank Number :  629
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Lexicon Pharmaceuticals is a biopharmaceutical company. Co. discovers the functions and pharmaceutical utility of genes and uses those gene function discoveries in the discovery and development of pharmaceutical products for the treatment of human disease. Co. is also developing sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes. Co. is developing LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain. In addition, Co. is conducting preclinical research and development and preparing to conduct clinical development of compounds from several additional drug programs.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 300,000 29,171,050 48,900,910
Total Buy Value $0 $306,417 $73,835,385 $123,160,035
Total People Bought 0 2 6 6
Total Buy Transactions 0 3 14 18
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 301
  Page 8 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-06-28 4 AB $12.45 $718,935 I/I 57,724 3,516,214     -
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-06-27 4 AB $12.54 $1,568,442 I/I 125,114 3,458,490     -
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-06-25 4 AB $12.95 $2,955,083 I/I 228,264 3,333,376     -
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-06-22 4 AB $13.36 $340,090 I/I 25,461 3,105,112     -
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-06-21 4 AB $13.27 $684,613 I/I 51,600 3,079,651     -
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-06-20 4 AB $13.28 $164,613 I/I 12,391 3,028,051     -
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-06-19 4 AB $13.45 $120,819 I/I 8,982 3,015,660     -
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-06-18 4 AB $13.06 $477,937 I/I 36,584 3,006,678     -
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-06-14 4 AB $12.66 $116,462 I/I 9,200 2,970,094     -
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-06-12 4 AB $12.83 $1,373,244 I/I 107,023 2,960,894     -
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-06-11 4 AB $12.75 $1,257,452 I/I 98,626 2,853,871     -
   Tessmer James F VP, Finance & Accounting   •       •      –    2018-06-08 4 S $12.91 $129,076 D/D (10,000) 25,643     -
   Tessmer James F VP, Finance & Accounting   •       •      –    2018-06-08 4 OE $10.15 $101,500 D/D 10,000 35,643     -
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-06-08 4 AB $12.89 $383,427 I/I 29,747 2,755,245     -
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-06-07 4 AB $12.93 $742,508 I/I 57,439 2,725,498     -
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-06-06 4 AB $12.58 $1,196,370 I/I 95,079 2,668,059     -
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-06-05 4 AB $12.45 $2,156,187 I/I 173,121 2,572,980     -
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-06-04 4 AB $12.24 $1,490,576 I/I 121,803 2,399,859     -
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-06-01 4 AB $12.22 $1,800,041 I/I 147,339 2,278,056     -
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-05-31 4 AB $11.62 $1,712,050 I/I 147,339 2,130,717     -
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-05-30 4 AB $10.32 $1,521,025 I/I 147,339 1,983,378     -
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-05-29 4 AB $9.84 $1,450,420 I/I 147,339 1,836,039     -
   Invus Public Equities Advisors, Llc Director   –       •       •   2018-05-25 4 AB $9.62 $1,334,974 I/I 138,700 1,688,700     -
   Santini Alexander A EVP and CCO   •       •      –    2018-05-23 4 B $9.78 $7,286 D/D 745 5,297 2.74     -
   Debbane Raymond Director   •       •      –    2018-04-27 4 A $0.00 $0 D/D 2,564 12,902     -
  301 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 8 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us